Mirae Asset Global ETFs Holdings
DSGN icon

Mirae Asset Global ETFs Holdings’s Design Therapeutics DSGN Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$121K Buy
11,363
+272
+2% +$2.75K ﹤0.01% 2589
2025
Q4 		$104K Buy
11,091
+367
+3% +$2.87K ﹤0.01% 2664
2025
Q3 		$80.8K Sell
10,724
-7,233
-40% -$36.2K ﹤0.01% 2761
2025
Q2 		$60.5K Sell
17,957
-780
-4% -$2.92K ﹤0.01% 2833
2025
Q1 		$72.3K Buy
18,737
+780
+4% +$3.72K ﹤0.01% 2756
2024
Q4 		$111K Buy
17,957
+760
+4% +$4.4K ﹤0.01% 2662
2024
Q3 		$92.5K Buy
17,197
+927
+6% +$4.36K ﹤0.01% 2748
2024
Q2 		$54.5K Buy
+16,270
New +$63.4K ﹤0.01% 2769

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Mirae Asset Global ETFs Holdings's DSGN Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Design Therapeutics (DSGN) stake by 2.5% in Q1 2026, buying an estimated $2.75K and bringing the position to 11,363 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #2589.

Mirae Asset Global ETFs Holdings first reported a position in DSGN in Q2 2024 and has held it in 8 quarters since. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 11,363 shares of Design Therapeutics worth $121K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 272 Design Therapeutics shares in Q1 2026, an estimated $2.75K.
  • Design Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2589 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Design Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.